Literature DB >> 9683806

The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).

M Engelhardt1, U M Martens.   

Abstract

Telomerase and telomeres have been shown to be involved in the control of cell proliferation, the regulation of cell senescence and the unlimited proliferation capacity of malignant cells. Human telomeres are specialized chromosomal end structures composed of TTAGGG repeats. They function to protect chromosomes from degradation, fusion and recombination. Since the termini of linear molecules are replicated only in the 5'-3' direction by conventional DNA polymerases and require an RNA primer to initiate DNA synthesis, the removal of the RNA primer results in DNA loss with each cell division. To date, telomere shortening has been observed in most dividing somatic cells, eventually leading to cell senescence when critically short telomeres are reached. Telomerase has been identified as a ribonucleoprotein enzyme that can synthesize telomeric repeats onto chromosomes. Borderline telomerase activity has been detected in human primitive hematopoietic cells and in stimulated lymphocytes which increased with cytokine induced ex vivo expansion. However, in most other normal somatic cells, telomerase has not been detected, and consequently telomere shortening can be anticipated after a limited number of population doublings. In contrast, spontaneously immortalized tumor cell lines and the majority of malignant tumors demonstrate high telomerase activity, stable telomere length and unlimited proliferative potential. Mechanisms for telomerase and telomere length regulation are under extensive investigation. These have included the cloning of the RNA component and telomerase associated proteins, antisense experiments that have demonstrated progressive telomere length shortening in the absence of telomerase, and the identification of telomere binding proteins which may regulate telomerase by creating a negative feedback signal. This review aims to summarize important results in the rapidly moving field of telomeres and telomerase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683806     DOI: 10.3892/or.5.5.1043

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Telomere maintenance in laser capture microdissection-purified Barrett's adenocarcinoma cells and effect of telomerase inhibition in vivo.

Authors:  Masood A Shammas; Aamer Qazi; Ramesh B Batchu; Robert C Bertheau; Jason Y Y Wong; Manjula Y Rao; Madhu Prasad; Diptiman Chanda; Selvarangan Ponnazhagan; Kenneth C Anderson; Christopher P Steffes; Nikhil C Munshi; Immaculata De Vivo; David G Beer; Sergei Gryaznov; Donald W Weaver; Raj K Goyal
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

2.  T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

Authors:  Rajendra N Damle; Sonal Temburni; Taraneh Banapour; Santanu Paul; Patricia K A Mongini; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-08-08       Impact factor: 22.113

3.  Telomeres and prognosis in patients with chronic lymphocytic leukaemia.

Authors:  Ludger Sellmann; Dirk de Beer; Marius Bartels; Bertram Opalka; Holger Nückel; Ulrich Dührsen; Jan Dürig; Marc Seifert; Dörte Siemer; Ralf Küppers; Gabriela M Baerlocher; Alexander Röth
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

4.  Structural RNAs of known and unknown function identified in malaria parasites by comparative genomics and RNA analysis.

Authors:  Kausik Chakrabarti; Michael Pearson; Leslie Grate; Timothy Sterne-Weiler; Jonathan Deans; John Paul Donohue; Manuel Ares
Journal:  RNA       Date:  2007-09-27       Impact factor: 4.942

5.  Unique C. elegans telomeric overhang structures reveal the evolutionarily conserved properties of telomeric DNA.

Authors:  Petra Školáková; Silvie Foldynová-Trantírková; Klára Bednářová; Radovan Fiala; Michaela Vorlíčková; Lukáš Trantírek
Journal:  Nucleic Acids Res       Date:  2015-04-08       Impact factor: 16.971

6.  Hairpins participating in folding of human telomeric sequence quadruplexes studied by standard and T-REMD simulations.

Authors:  Petr Stadlbauer; Petra Kührová; Pavel Banáš; Jaroslav Koča; Giovanni Bussi; Lukáš Trantírek; Michal Otyepka; Jiří Šponer
Journal:  Nucleic Acids Res       Date:  2015-10-03       Impact factor: 16.971

7.  TERT rs2736098 (Ex2-659G>A) polymorphism and cancer susceptibility: evidence from a comprehensive meta-analysis.

Authors:  Tingyuan Pang; Minjie Zhou; Rumin Liu; Jia Luo; Renfei Xia
Journal:  Oncotarget       Date:  2017-10-09

8.  Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growth.

Authors:  R Lu; J Pal; L Buon; P Nanjappa; J Shi; M Fulciniti; Y-T Tai; L Guo; M Yu; S Gryaznov; N C Munshi; M A Shammas
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.